XML 50 R41.htm IDEA: XBRL DOCUMENT v3.23.2
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract]  
Summary of impact of the restatement on the financial statements
               
   As Previously   Restatement     
   Reported   Adjustment   As Restated 
Unaudited Statement of Operations for the Three Months Ended June 30, 2022               
Gain on forgiveness of deferred underwriting fee payable   9,660,000    (9,288,090)   371,910 
Total other income (expenses)   10,396,046    (9,288,090)   1,107,956 
Income (loss) before benefit from (provision for) income taxes   10,094,313    (9,288,090)   806,223 
Net Income   10,071,447    (9,288,090)   783,357 
Basic and diluted weighted average shares outstanding - Class A common stock   14,481,736    -    14,481,736 
Basic and diluted earnings per share - Class A common stock  $0.47   $(0.43)  $0.04 
Basic and diluted weighted average shares outstanding - Class B common stock   6,900,000    -    6,900,000 
Basic and diluted earnings per share - Class B common stock  $0.47   $(0.43)  $0.04 

 

   As Previously   Restatement     
   Reported   Adjustment   As Restated 
Unaudited Statement of Operations for the Six Months Ended June 30, 2022               
Gain on forgiveness of deferred underwriting fee payable   9,660,000    (9,288,090)   371,910 
Total other income (expenses)   18,587,467    (9,288,090)   9,299,377 
Income (loss) before benefit from (provision for) income taxes   17,962,482    (9,288,090)   8,674,392 
Net Income   17,939,616    (9,288,090)   8,651,526 
Basic and diluted weighted average shares outstanding - Class A common stock   21,004,630    -    21,004,630 
Basic and diluted earnings per share - Class A common stock  $0.64   $(0.33)  $0.31 
Basic and diluted weighted average shares outstanding - Class B common stock   6,900,000    -    6,900,000 
Basic and diluted earnings per share - Class B common stock  $0.64   $(0.33)  $0.31 

 

   As Previously   Restatement     
   Reported   Adjustment   As Restated 
Unaudited Statement of Operations for the Nine Months Ended September 30, 2022               
Gain on forgiveness of deferred underwriting fee payable   9,660,000    (9,288,090)   371,910 
Total other income (expenses)   20,560,364    (9,288,090)   11,272,274 
Income (loss) before benefit from (provision for) income taxes   18,838,653    (9,288,090)   9,550,563 
Net Income   18,811,924    (9,288,090)   9,523,834 
Basic and diluted weighted average shares outstanding – Class A common stock   16,466,455    -    16,466,455 
Basic and diluted earnings per share – Class A common stock  $0.81   $(0.40)  $0.41 
Basic and diluted weighted average shares outstanding - Class B common stock   6,900,000    -    6,900,000 
Basic and diluted earnings per share - Class B common stock  $0.81   $(0.40)  $0.41 

 

   As Previously   Restatement     
   Reported   Adjustment   As Restated 
Statement of Operations for the Year Ended December 31, 2022               
Gain on forgiveness of deferred underwriting fee payable   9,660,000    (9,288,090)   371,910 
Total other income (expenses)   20,634,549    (9,288,090)   11,346,459 
Income (loss) before benefit from (provision for) income taxes   17,684,085    (9,288,090)   8,395,995 
Net Income   17,634,910    (9,288,090)   8,346,820 
Basic and diluted weighted average shares outstanding - Class A common stock   12,546,423    -    12,546,423 
Basic and diluted earnings per share - Class A common stock  $0.91   $(0.48)  $0.43 
Basic and diluted weighted average shares outstanding - Class B common stock   6,900,000    -    6,900,000 
Basic and diluted earnings per share - Class B common stock  $0.91   $(0.48)  $0.43 

 

Unaudited Statement of Changes in Stockholders’ Deficit for the Three Months Ended June 30, 2022

 

   Accumulated Deficit 
   As Previously         
   Reported   Adjustment   As Restated 
Balance – March 31, 2022  $(13,226,270)  $-   $(13,225,580)
Net income   10,071,447    (9,288,090)   783,357 
Accretion of Class A common stock to redemption value   (242,995)   9,288,090    9,045,095 
Balance – June 30, 2022  $(3,397,818)  $-   $(3,397,128)

 

Statement of Changes in Stockholders’ Deficit for the Year Ended December 31, 2022

 

   Accumulated Deficit 
   As Previously         
   Reported   Adjustment   As Restated 
Balance – December 31, 2021  $(21,094,439)  $-   $(21,094,439)
Net income   17,634,910    (9,288,090)   8,346,820 
Accretion of Class A common stock to redemption value   (256,545)   9,288,090    9,031,545 
Balance – December 31, 2022  $(3,716,074)  $-   $(3,716,074)

 

   As Previously   Restatement     
   Reported   Adjustment   As Restated 
Unaudited Statement of Cash Flows for the Six Months Ended June 30, 2022               
Net Income   17,939,616    (9,288,090)   8,651,526 
Gain on forgiveness of deferred underwriting fee payable   (9,660,000)   9,288,090    (371,910)
Non-Cash Investing and Financing Activities               
Extinguishment of deferred underwriting fee payable allocated to public shares   -    (9,288,090)   (9,288,090)

 

   As Previously   Restatement     
   Reported   Adjustment   As Restated 
Unaudited Statement of Cash Flows for the Nine Months Ended September 30, 2022               
Net Income   18,811,924    (9,288,090)   9,523,834 
Gain on forgiveness of deferred underwriting fee payable   (9,660,000)   9,288,090    (371,910)
Non-Cash Investing and Financing Activities               
Extinguishment of deferred underwriting fee payable allocated to public shares   -    (9,288,090)   (9,288,090)

 

   As Previously   Restatement     
   Reported   Adjustment   As Restated 
Statement of Cash Flows for the Year Ended December 31, 2022               
Net Income   17,634,910    (9,288,090)   8,346,820 
Gain on forgiveness of deferred underwriting fee payable   (9,660,000)   9,288,090    (371,910)
Non-Cash Investing and Financing Activities               
Extinguishment of deferred underwriting fee payable allocated to public shares   -    (9,288,090)   (9,288,090)